Accurate and timely national estimates of the prevalence of birth defects are needed for monitoring trends, assessing prevention efforts, determining service planning, and understanding the burden of disease due to birth defects in the United States.
Background
Using the National Birth Defects Prevention Network (NBDPN) annual data report, U.S. national prevalence estimates for major birth defects are developed based on birth cohort 2010–2014.
Methods
Data from 39 U.S. population‐based birth defects surveillance programs (16 active case‐finding, 10 passive case‐finding with case confirmation, and 13 passive without case confirmation) were used to calculate pooled prevalence estimates for major defects by case‐finding approach. Fourteen active case‐finding programs including at least live birth and stillbirth pregnancy outcomes monitoring approximately one million births annually were used to develop national prevalence estimates, adjusted for maternal race/ethnicity (for all conditions examined) and maternal age (trisomies and gastroschisis). These calculations used a similar methodology to the previous estimates to examine changes over time.
Results
The adjusted national birth prevalence estimates per 10,000 live births ranged from 0.62 for interrupted aortic arch to 16.87 for clubfoot, and 19.93 for the 12 critical congenital heart defects combined. While the birth prevalence of most birth defects studied remained relatively stable over 15 years, an increasing prevalence was observed for gastroschisis and Down syndrome. Additionally, the prevalence for atrioventricular septal defect, tetralogy of Fallot, omphalocele, and trisomy 18 increased in this period compared to the previous periods. Active case‐finding programs generally had higher prevalence rates for most defects examined, most notably for anencephaly, anophthalmia/microphthalmia, trisomy 13, and trisomy 18.
Conclusion
National estimates of birth defects prevalence provide data for monitoring trends and understanding the impact of these conditions. Increasing prevalence rates observed for selected conditions warrant further examination.
Abstract. A coupled physical-biogeochemical climate model that includes a dynamic global vegetation model and a representation of a coupled atmosphere-ocean general circulation model is driven by the nonintervention emission scenarios recently developed by the Intergovernmental Panel on Climate Change (IPCC). Atmospheric CO2, carbon sinks, radiative forcing by greenhouse gases (GHGs) and aerosols, changes in the fields of surface-air temperature, precipitation, cloud cover, ocean thermal expansion, and vegetation structure are projected. Up to 2100, atmospheric CO2 increases to 540 ppm for the lowest and to 960 ppm for the highest emission scenario analyzed. Sensitivity analyses suggest an uncertainty in these projections of-10 to +30% for a given emission scenario. Radiative forcing is estimated to increase between 3 and 8 W m -2 between now and 2100. Simulated warmer conditions in North America and Eurasia affect ecosystem structure: boreal trees expand poleward in high latitudes and are partly replaced by temperate trees and grasses at lower latitudes. The consequences for terrestrial carbon storage depend on the assumed sensitivity of climate to radiative forcing, the sensitivity of soil respiration to temperature, and the rate of increase in radiative forcing by both CO2 and other GHGs. In the most extreme cases, the terrestrial biosphere becomes a source of carbon during the second half of the century. High GHG emissions and high contributions of non-CO2 agents to radiative forcing favor a transient terrestrial carbon source by enhancing warming and the associated release of soil carbon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.